Precision BioSciences (DTIL) Appoints Sam Wadsworth to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Precision BioSciences (DTIL) Tops Q2 EPS by 40c; Reports Cash and Cash Equivalents of $160.5M
November 10, 2021 7:13 AM ESTPrecision BioSciences (NASDAQ: DTIL) reported Q2 EPS of ($0.19), $0.40 better than the analyst estimate of ($0.59). Revenue for the quarter came in at $24 million versus the consensus estimate of $6.02 million.
For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.
... More